Everything About Pneumococcal Conjugate Vaccines

The achievements of vaccines are often compared to magic. Some facts that depict the accomplishments of vacciniums are:-

• The total number of children deaths is reduced by half
• Eradication of smallpox
• Worldwide polio incidences are dropped to 99%
• Polio is fully controlled in the western hemisphere
• 90% reduction in the total number of deaths in Africa
• Absolute controlling of measles in the US and parts of Europe

Scientific innovations help develop and deliver new vaccines, controlling diseases that are highly infectious. Vaccination’s health impact is increasing continually. Several research projects are underway to develop conjugate pneumococcal vaccine and reduce hepatitis A vaccine cost.

The challenge for vaccine development companies

Many prominent Indian vaccine research laboratories are working to develop pneumococcal conjugate vaccine India. The development of vaccines is taking the center stage due to the emergence of populous nations – India, China, Brazil, Russia, etc. Catering to the growing requirements of these middle-income, populous countries is a primary challenge for vaccine industries and policy makers.

Most research companies develop ways to control the cost of vacciniums production. The common aim of many research laboratories is to let the world have access to economical vaccines.

Position of vaccination in the public health sector

Healthy lifestyle is wished by many. A healthy lifestyle helps in:-

• Avoiding the occurrence of diseases
• Averting the costs of treatment and care
• Preventing economic consequences that can occur due to loss of work and/or lower productivity

All in all, vaccination can help in building a healthy environment at home as well as workplace. Vaccinations can also serve as the point of contact for an entire family. Research works, by and large, are directed toward a vaccinium’s affordability, availability and sustainability. Hence, it’s evident that immunization is the best way of having public health interventions.

An Introductory Guide To The Vaccine Of Pneumococcal

The most common cause of blood infection, pneumonia, meningitis and ear infection has been a Streptococcus pneumonia bacterium. All of these diseases come under the category of pneumococcal disease. The disease is common during early spring as well as winter and spreads from person-to-person. Some cases of pneumococcal infection have culminated to extensive brain damage. Few invasive pneumococcal infections can also take the life of infants. 

Who should be given a pneumococcal vaccine?

Primarily, the pneumococcal vaccine is administered on three types of individuals –

•  Infants (under the age of 2)
• Old people (above the age of 65)
• Young adults and children having serious kidney or heart condition derived from pneumococcal disease itself

 How often PCV13 is given?

• The infants receive three separate injections – one at two months, followed by another at four months and the last one when during 12-13 months after the birth.
• Senior adults – over the age of 65 years – require a single vaccination, protecting them for life
• The adults and young children require one pneumococcal vaccination or a five-yearly vaccination, depending on the criticality of the health problem.

 Variants of pneumonia vaccine

  

There are two kinds of pneumococcal vaccine:-

• Pneumococcal conjugate vaccine (PCV, Prevnar 13 or PCV13) – The pneumococcal conjugate vaccine is administered on infants under the age of two. In some countries, the vaccine has become an integral part of the childhood vaccination program.  The development of pneumococcal conjugatevaccine India has risen to a new high with several leading vaccine laboratories contributing in its production.  
• Pneumococcal polysaccharide vaccine (PPV) – This is another vaccine, which is administered on people of age 65 and above. Also, the vaccine is given to those people having a continuing health condition.

 Close to 90 types of pneumococcal bacterium have been identified; although, eight to ten of them cause fatal infection. The PCV13 gives protection against 13 strains; similarly, PPV gives protection against nearly 23 strains. With the progresses in medicine, the vaccine development laboratories will soon come up with holistic cures for some of the ills such as pneumonia.